It has long been known that rates of breast and cervical cancer screening among Latinas are low compared to rates for U.S. women overall. A study led by researchers at Roswell Park Cancer Institute (RPCI) found that age and fear of cancer diagnosis...
24-Jul-2015 11:30 AM EDT
Tobacco cessation provided significant survival benefit for lung cancer patients who quit smoking shortly before or after diagnosis, despite the severity of the disease. Results of the Roswell Park Cancer Institute study were published in the...
13-Jul-2015 2:05 PM EDT
Roswell Park Cancer Institute will provide clinical consultations and training for staff at Lakeshore Cancer Center, Lagos, Nigeria, through an affiliation announced today.
30-Jun-2015 1:05 PM EDT
Early Menarche May Be Important in Development of Aggressive Breast Cancer in African-American Women
Early age at menarche, or first menstrual cycle, could play a role in the disproportionate incidence of estrogen receptor (ER)-negative breast cancers diagnosed among African-American women, according to a study published in the Journal of the...
17-Jun-2015 3:00 PM EDT
Roswell Park Photodynamic Therapy Center Receives $10M Federal Award to Optimize Head & Neck Cancer Treatments
Roswell Park will receive a five-year, $10 million NCI award to continue its PDT research program in head and neck cancers and conduct clinical trials in collaboration with other centers.
16-Jun-2015 2:05 PM EDT
OmniSeq, LLC has officially begun its spin-out from Roswell Park Cancer Institute and will immediately begin commercializing its suite of innovative products that match cancer patients to therapies tailored specifically to them.
11-Jun-2015 8:45 AM EDT
Blood and Marrow Transplantation (BMT) is a potentially curative treatment for patients with leukemia or other life-threating blood diseases. With a goal of increasing survival rates, a research team led by Roswell Park Cancer Institute (RPCI)...
9-Jun-2015 4:00 PM EDT
Phase III Study Confirms Benefits of Lenalidomide Maintenance Therapy for Patients with Multiple Myeloma
A large cooperative-group study has confirmed previous evidence that lenalidomide delays time to disease progression for patients with multiple myeloma and is an important treatment option for patients with the disease.
31-May-2015 7:00 AM EDT
Clinical trials are the frontier for targeted cancer drugs. Roswell Park Cancer Institute recently opened one of only a few clinical research centers in the U.S. focused exclusively on cancer. The Clinical Research Center, under the direction of...
4-Apr-2008 1:00 PM EDT